CytoMed Therapeutics Stock (NASDAQ: GDTC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 468.00 / 67.98K |
Day Range | - - - |
52 Wk Range | 1.36 - 5.50 |
Market Cap | $16.04M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 7.37% |
Days to Cover | 28.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CytoMed Therapeutics (NASDAQ:GDTC) through any online brokerage.
Other companies in CytoMed Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Evaxion Biotech (NASDAQ:EVAX).
There is no analysis for CytoMed Therapeutics to provide a consensus price target.
The stock price for CytoMed Therapeutics (NASDAQ: GDTC) is $1.39 last updated September 13, 2024 at 8:21 AM EDT.
There are no upcoming dividends for CytoMed Therapeutics.
CytoMed Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for CytoMed Therapeutics.
CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.